CORT Crosses Above Average Analyst Target
February 27, 2017 at 09:09 AM EST
In recent trading, shares of Corcept Therapeutics Inc (CORT) have crossed above the average analyst 12-month target price of $8.75, changing hands for $8.85/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..